Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra K Farver

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Safety|August 9, 2003
Neuroleptic malignant syndrome induced by atypical antipsychoticsDebra K Farver
The Annals of Pharmacotherapy|February 3, 2012
Gabapentin enacarbil for treatment of restless legs syndrome in adultsWilliam J Hayes, Michael D Lemon, Debra K Farver
The Annals of Pharmacotherapy|March 2, 2006
Sodium oxybate for cataplexyMichael D Lemon, Joe D Strain, Debra K Farver
The Annals of Pharmacotherapy|March 24, 2005
Ramoplanin: a lipoglycodepsipeptide antibioticDebra K Farver, Dennis D Hedge, Steven C Lee
Clinical Pharmacology : Advances and Applications|February 1, 2012
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapyJoe D Strain, Debra K Farver, James R Clem
Risk Management and Healthcare Policy|February 8, 2012
Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?James R Clem, Joe D Strain, Debra K Farver
Current Drug Safety|March 10, 2010
Dronedarone: a safety comparison to amiodaroneJames R Clem, Debra K Farver, Janet R Fischer, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 19, 2007
Case report of hantavirus pulmonary syndrome and reviewDavid M Bartholomew, Lori A Hansen, John J Frank, et al.
Drug Design, Development and Therapy|November 19, 2009
Indiplon in the management of insomniaMichael D Lemon, Joe D Strain, Annie M Hegg, et al.
Journal of Clinical Pharmacology|April 11, 2017
Brivaracetam: An Adjunctive Treatment for Partial-Onset SeizuresJohn A Kappes, William J Hayes, Joe D Strain, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Safety|August 9, 2003
Neuroleptic malignant syndrome induced by atypical antipsychoticsDebra K Farver
The Annals of Pharmacotherapy|February 3, 2012
Gabapentin enacarbil for treatment of restless legs syndrome in adultsWilliam J Hayes, Michael D Lemon, Debra K Farver
The Annals of Pharmacotherapy|March 2, 2006
Sodium oxybate for cataplexyMichael D Lemon, Joe D Strain, Debra K Farver
The Annals of Pharmacotherapy|March 24, 2005
Ramoplanin: a lipoglycodepsipeptide antibioticDebra K Farver, Dennis D Hedge, Steven C Lee
Clinical Pharmacology : Advances and Applications|February 1, 2012
A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapyJoe D Strain, Debra K Farver, James R Clem
Risk Management and Healthcare Policy|February 8, 2012
Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?James R Clem, Joe D Strain, Debra K Farver
Current Drug Safety|March 10, 2010
Dronedarone: a safety comparison to amiodaroneJames R Clem, Debra K Farver, Janet R Fischer, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 19, 2007
Case report of hantavirus pulmonary syndrome and reviewDavid M Bartholomew, Lori A Hansen, John J Frank, et al.
Drug Design, Development and Therapy|November 19, 2009
Indiplon in the management of insomniaMichael D Lemon, Joe D Strain, Annie M Hegg, et al.
Journal of Clinical Pharmacology|April 11, 2017
Brivaracetam: An Adjunctive Treatment for Partial-Onset SeizuresJohn A Kappes, William J Hayes, Joe D Strain, et al.
Pageof 2